Charts
From 02/05/2022 our Markets Data content will no longer be free to read. To continue to get full access, subscribe now and receive 25% off.
Equities

Humanwell Healthcare Group Co Ltd

600079:SHH

Humanwell Healthcare Group Co Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (CNY)21.28
  • Today's Change-0.270 / -1.25%
  • Shares traded17.04m
  • 1 Year change-8.51%
  • Beta0.9055
Data delayed at least 15 minutes, as of Nov 01 2024 07:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Humanwell Healthcare Group Co Ltd is a China-based company principally engaged in the research and development, production and sales of pharmaceuticals. The Company primarily operates its businesses through two segments. Pharmaceutical segment is mainly engaged in the research and development, production and sales of pharmaceutical products and the research and development, production and sales of medical device products, as well as the delivery, distribution and related businesses of pharmaceutical products, providing drugs, devices, medical equipment, reagents, consumables, health products, as well as technology and management services. The Company's products include chemical pharmaceutical preparations, chemical active pharmaceutical ingredients and others. Environmental Protection segment is primarily engaged in environmental protection engineering business.

  • Revenue in CNY (TTM)25.56bn
  • Net income in CNY1.96bn
  • Incorporated1993
  • Employees17.68k
  • Location
    Humanwell Healthcare Group Co LtdNo. 666 Gaoxin AvenueDonghu High-Tech DistrictWUHAN 430075ChinaCHN
  • Phone+86 2 787597232
  • Fax+86 2 787596393
  • Websitehttp://www.humanwell.com.cn
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
600079:SHH since
announced
Transaction
value
PAION AGAnnounced22 Dec 202322 Dec 2023Announced-17.13%--
Data delayed at least 15 minutes, as of Nov 01 2024 07:00 BST.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Hubei Jumpcan Pharmaceutical Co Ltd8.92bn2.78bn27.84bn5.23k9.971.98--3.123.033.039.7115.270.51353.084.601,706,101.0016.0416.2320.6820.8878.3682.6431.2324.423.55--0.102441.767.326.0230.0410.83-14.701.11
Gan & Lee Pharmaceuticals2.95bn580.86m29.43bn4.48k50.102.63--9.980.97730.97734.9718.650.25580.84588.94657,602.005.048.305.408.8372.9285.3919.7126.446.77--0.000513.6552.311.78177.37-18.301.50--
Bluestar Adisseo Co14.95bn1.09bn29.45bn2.73k27.021.86--1.970.40640.40645.575.900.68875.188.015,466,479.005.035.286.076.9429.2030.317.308.761.167.830.110521.81-9.262.92-95.82-43.752.74-19.09
Xiamen Amoytop Biotech Co Ltd2.60bn740.69m31.46bn1.96k42.4713.89--12.121.821.826.385.571.080.89286.181,324,099.0030.7317.9635.9021.0292.7190.4828.5419.173.60--0.004426.9537.5536.1993.52103.2881.61--
Humanwell Healthcare Group Co Ltd25.56bn1.96bn35.17bn17.68k17.781.97--1.381.211.2115.8710.950.69023.802.741,445,825.007.136.2013.1212.7245.5942.8210.339.841.2112.090.317118.879.795.65-14.07--8.25--
Beijing Tiantan Biological Products Corp5.23bn1.27bn42.61bn4.86k33.444.00--8.140.64440.64442.655.380.34710.8137198.921,076,946.0011.4711.7116.7516.5054.2349.3933.0527.713.31--0.004616.6721.5712.0625.9916.8529.6738.97
Data as of Nov 01 2024. Currency figures normalised to Humanwell Healthcare Group Co Ltd's reporting currency: Chinese Yuan Renminbi CNY

Institutional shareholders

14.69%Per cent of shares held by top holders
HolderShares% Held
Harvest Fund Management Co., Ltd.as of 30 Jun 202453.57m3.47%
China Merchants Fund Management Co., Ltd.as of 30 Sep 202339.69m2.57%
Penghua Fund Management Co., Ltd.as of 30 Jun 202431.97m2.07%
China Universal Asset Management Co., Ltd.as of 30 Jun 202420.74m1.34%
Zhong Ou Asset Management Co., Ltdas of 30 Sep 202319.03m1.23%
China Southern Asset Management Co., Ltd.as of 30 Jun 202417.29m1.12%
GF Fund Management Co., Ltd.as of 30 Sep 202312.83m0.83%
Invesco Great Wall Fund Management Co. Ltd. (Invt Mgmt)as of 30 Jun 202410.84m0.70%
Yinhua Fund Management Co., Ltd.as of 30 Jun 202410.54m0.68%
Morgan Stanley Huaxin Fund Management Co., Ltd.as of 30 Jun 202410.23m0.66%
More ▼
Data from 30 Jun 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.